THE EFFECT OF A GROWTH-RETARDING FACTOR FROM NORMAL TISSUES ON SPONTANEOUS CANCER OF MICE by Murphy, James B. & Sturm, Ernest
THE  EFFECT  OF A  GROWTH-RETARDING  FACTOR  FROM 
NORMAL TISSUES  ON SPONTANEOUS  CANCER OF 
MICE* 
BY JAMES B. MURPHY, M.D., ANn ERNEST STURM 
(From the Laboratories of The Rockefeller Institute for Medical Research) 
(Received for publication, June 21, 1934) 
Extracts  of placenta  and  embryo skin  have  a  definite  inhibiting 
action  on  the  growth  of  transplantable  cancers  of mice  (1).  The 
absence of any effect of these materials  on sarcomas, and the finding 
that  the  inhibiting  factor isolated from certain  fowl tumors acts on 
sarcomas and not on carcinomas, suggested a degree of tissue specificity 
for these  factors.  The  attempt  to  establish a  principle  applying  to 
cancer in general on evidence derived from the transplantable  tumors 
only leaves something to be desired, for these tumors always represent 
cells foreign  to  the  host  that  maintains  them.  Therefore,  we have 
deemed it necessary to test the above mentioned factor on the spon- 
taneous or natural  cancers made up of malignant  cells derived from 
the animal's own tissues (2). 
The  mammary  tumors  of mice  have  been  studied  because of the 
number available as by-products of the genetic studies,  and because 
of the  extensive data  available on  the  natural  history of these  neo- 
plasms.  There is a  surprising uniformity in the figures published by 
different investigators,  using different strains of mice, on such points 
as the growth of autografts, local recurrence following surgical removal, 
spontaneous retrogression, and multiple loci of malignant change.  In 
the present communication a report will be made on both the local and 
general effect upon these natural  cancers of inhibiting materials  that 
are known to act on transplanted tumors. 
Materials 
The  tumor  mice utilized came from three principal  sources, and  were from 
several strains.  The  largest  number  were from  the general breeding room of 
* This investigation was carried out under the Rutherford Donation. 
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The Rockefeller Institute, where the stock of Swiss origin is inbred  though not a 
pure line strain.  Figures for the tumor rate, while known to be high, cannot be 
accurately determined  by the  available  records.  The  second  source  was  our 
genetic breeding room, where the mammary tumor strains  are descendents of the 
original Abbe Lathrop stock.  The third source, and the second largest,  was the 
Roscoe Jackson Memorial Laboratory, and the animals came from several strains 
of high tumor incidence.  The size of the tumors at the time that the mice were 
sent into the laboratory was rarely under 1.0 x 0.9 cm. and rarely over 1.8 x 1.5 cm. 
About 29 per cent of the animals had more than one primary tumor. 
The extracts of mouse placenta and embryo skin were prepared in the manner 
described in earlier publications.  The material,  collected during the latter part of 
pregnancy, was minced, spread  in a thin layer,  and placed in a vacuum jar over 
sulfuric acid.  After evacuation it was kept in the freezing box until desiccation 
was  complete.  The  finely  powdered  material  was  thoroughly extracted  with 
water (0.1 gin. to 1 cc.) and centrifuged.  The supernatant fluid was used for the 
tests. 
Effect of the Extracts  on Local Postoperative Recurrence 
The early invasion of the skin or deeper tissues by mammary cancer 
in mice is unusual.  Probably owing to  the  looseness of the  tissues, 
the tumors grow as more or less discrete masses in the  subcutaneous 
tissue  and  can  be  easily  separated.  In  spite  of  the  apparent  dis- 
creteness of the masses and the removal of all immediately  adjacent 
normal tissue, local recurrence is not uncommon.  The first tests were 
on the effect of the inhibiting extract on this manifestation. 
Experiment.--The group was composed of 58 tumors removed and the wound 
bathed with embryo skin extract and 100 tumors removed and the operative field 
similarly  treated  with placenta  extract.  The operation  consisted  of  a  radical 
removal from the etherized animal of the tumor and adjacent tissue, under aseptic 
precautions.  After the wound was sutured,  from 0.05 to 0.2  cc. of the tumor 
extract, depending on the size of the wound, was injected into the area and then it 
was sealed with collodion to prevent leakage.  In the controls collodion was used 
in the same way.  There was rarely any evidence of infection  and healing  took 
place promptly.  No further treatments were given and the animals  were kept 
under close observation  until their death.  Diagnosis was made by sections of the 
original  tumors and any nodules  found at autopsy were removed and also sec- 
tioned.  No animals  were included  as negative  for local recurrence  unless  they 
survived  over 5 weeks.  The average length of life after operation was approxi- 
mately 3 months for the group. 
The  results  are  shown in  Table  I, which for  comparison  includes 
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treatment,  two  earlier series from this  laboratory,  and  two  groups 
reported by other investigators. 
The recurrence rate following operative removal of mouse cancers 
reported  by  different investigators with  different strains  of mice is 
remarkably  constant,  the  maximum  variation  between  the  groups 
being from 46.2  per cent to  54.0  per cent.  The constancy of these 
figures gives even greater significance to the evidence of suppression 
TABLE  I 
Local Recurrence Following Operation 
Controls 
Murray*.. 
Haalandt 
Murphy and Morton~ 
Nakahara§ ..... 
Present series. 
Total controls. 
Placenta treated.. 
Embryo skin treated.. 
No. operated 
48 
174 
39 
50 
144 
455 
100 
59 
No. recurred 
23 
96 
18 
26 
69 
232 
6 
15 
Percentage 
recurrence 
47.9 
54.0 
46.2 
52.0 
47.9 
50.9 
6.0 
25.9 
* Murray, J.  A., 3rd Scient.  Rep. Inv.  Imp.  Cancer Research Fund, 
1908, 69. 
t Haaland,  M.,  4th  Scient.  Rep.  Inv.  Imp.  Cancer Research Fund, 
1911,  1. 
~: Murphy, Jas. B., and Morton, J. J., Y. Exp. Med., 1915, ~-, 800. 
§ Nakahara, W., J. Exp. Med., 1925, 41,347. 
London, 
London, 
of local recurrence by the two tissue extracts, particularly by placenta 
extract.  While the figures for skin extract show a significant reduction 
over the expected recurrence rate it is doubtful if this represents the 
full potency of the material.  The larger number of recurrences in this 
group took place in a lot of animals treated with a single preparation 
which was probably inactive; but this was not evident until too  late 
to make further tests to establish the point.  There seems no doubt 
that there is a  definite reduction in local recurrence due to the treat- 
ment of the operative field with the tissue extracts. 308  INHIBITING FACTOR  AND  SPONTANEOUS  CANCER 
The Influence of the  Tissue Extracts  on  the Fate  of Autografls  from 
Spontaneous  Tumors 
The  autograft  of a  spontaneous  tumor  may be  considered  as  an 
artificial metastasis and as such might be expected to grow in practi- 
caUy every instance.  As a  matter of fact, the percentage of takes is 
so high that it is probable that the failures are due to  accidental loss 
of the graft through extrusion or destruction by local infection. 
Experiments.--The experimental group for this test consisted of 111 
mice with spontaneous mammary cancer.  The primary tumors were 
removed surgically, and from the outer surface two large sized grafts 
were cut out.  One of these was immersed for a  few moments in one 
of the test fluids and the other in Ringer's solution for the same length 
of time.  The  two grafts were then  reinoculated into  opposite sides 
of the host of origin.  The operation wound was also treated with the 
tissue  extract.  No  further  treatment  was  given  to  these  animals 
and they were kept under observation for their duration of fife.  The 
diagnosis of the original  tumors and the fates of the autografts were 
confirmed by microscopic sections. 
The  results are presented in two ways for better comparison.  In 
Table II the figures are given for takes of the treated and untreated 
autografts in the same animals.  Table III shows the  figures for the 
untreated  autografts  compared  with a  larger  number  of controls  in 
which autografts had been returned to animals without treatment  of 
the animal or graft. 
The figures for the growth of autografts collected in this  laboratory 
and those reported by others are remarkably uniform, with the greatest 
variation between groups of 1.9 per cent.  The failure of takes in 10.9 
per  cent  and  18.5  per  cent  of the  untreated  grafts  inoculated  into 
animals  which  had  received a  treated  graft  and  whose  wound  had 
been flushed with one of the tissue extracts, suggested that  there is a 
general effect from the local injections.  Here, as with the first experi- 
ments, it is doubtful if the figures for the effect of embryo skin extract 
give the correct idea of the full strength of this factor.  Most of the 
positive grafts occurred in a lot of mice treated with an extract which 
we  have  reason  to  believe was  inactive  as  stated  in  the  foregoing 
experiment.  The  results  cannot  be  explained  on  a  possible  inter- 
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published study, in which 52 double autografts were made,  showed 
that in 86.5 per cent both grew, and in only 7 per cent one grew and the 
TABLE  II 
Effect of Embryo Skin and Placenta Extracts on Autografts of Tumors 
No. which grew  Per cent which  Per cent  doubtful or no 
grew  growth 
!6 tumors removed 
Autografts treated with embryo skin extract. 
Autografts not treated ...... 
55 tumors removed 
Autografts treated with placenta extract... 
Autografts not treated. 
54 tumors removed 
Autografts, no treatment of graft or wound.. 
29 
41 
21 
53 
63.1 
89.1 
32.3 
81.5 
36.9 
10.9 
67.7 
18.5 
62  96.9  3.1 
No.  Per cent 
Autografts treated with embryo skin, negative or definitely 
smaller than control  ...................................  33  71.7 
Autografts  treated  with  placenta, negative  or  definitely 
smaller than control ..................................  63  96.9 
TABLE  III 
Growth of Autografts 
No. of  No. which grew  Per cent which 
autografts  grew 
Controls 
Haaland* .............................. 
Murphy and Morton* ................... 
Nakahara* ............................ 
Additional Rockefeller Institute series  ..... 
Total  controls ........................... 
Placenta treated .......................... 
Embryo skin treated ....................... 
62 
29 
25 
202 
318 
65 
46 
60 
28 
24 
192 
304 
21 
28 
96.9 
96.6 
96.0 
95.0 
95.6 
32.3 
60.9 
* For references see Table I. 
other  did  not.  The  retardation  of  growth  of  tumors  resulting  from 
the treated  graft, where  inhibition  was not complete,  was very  evident. 310  INHIBITING  FACTOR  AND  SPONTANEOUS  CANCER 
The Distal  Effect  of Inhibiting  Factors  on  Tumors 
The history of the established spontaneous cancers of mice, particu- 
larly the mammary tumors, has been studied by a  number of investi- 
gators.  The most complete data are those collected by Haaland  (3) 
based on 353 tumors and those by Woglom (4) based on 2000 tumors. 
Haaland  found five, or  1.4 per cent which retrogressed more or less 
completely, while Woglom had only 0.8 per cent which did not show a 
progressive  course.  Our  figures  would  be  close  to  Woglom's.  We 
have  not  seen  a  well  estabUshed  tumor  retrogress  among  the  large 
number which  have  been  followed in  this  laboratory.  There was  a 
suggestion of an effect on the control graft when the inhibiting extracts 
were injected into another part of the body, in the test just described. 
In the next experiments we have considered its possible action on an 
established primary tumor when injected at a distance. 
Experiment.--In this group there were 142 primary tumors, 75 of which were 
treated by intraperitoneal injection of placenta extract and 67 with embryo skin 
extract.  The injections of 1 cc. were made at weekly intervals, from six to fifteen 
injections,  depending on the response of the tumor.  A small piece was removed 
for diagnosis  before the injections were started, in half the animals,  and in the 
other half after the tumor had become stationary, or at autopsy.  Otherwise  the 
tumors were not interfered with.  As there was no difference in the outcome of the 
treatments these animals were all grouped together.  Weekly measurements were 
made and complete autopsies were performed at death.  No tumors were included 
in the series unless the animal lived more than 5 weeks, except those dying as the 
result of growth of the tumors.  The general health of the mice seemed unaffected 
by the treatment. 
The results are shown in Table IV. 
Among  the  two groups  there were 45  tumors which  continued to 
grow but apparently at a slower rate than in an untreated series.  The 
average progress of 43 of these treated tumors in animals which lived 
for 4 weeks, compared with 41 of an untreated group is shown in Text- 
fig. 1.  A  comparison of this control group with a  large number from 
earlier studies on growth rate shows this to be a fair average. 
The growth-inhibiting action of the two tissue extracts is evidenced 
by the fact that 67 per cent and 69 per cent of the two groups treated 
showed no further growth of the tumors after the injections had been 
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life, a number of the animals having survived over 6 months and two 
over a year.  The tumors not completely stopped progressed at what 
appeared to be a slower rate than is usually shown by tumors of this 
type.  The difference in effectiveness between the skin and placenta 
extracts is not marked here, for the use of an inactive preparation in 
one of a  series of injections would not be so noticeable as in the first 
two experiments in which a single treatment was given. 
TABLE  IV 
Effect  of Embryo  Skin  and  Placenta  Extracts  on  ,5 
Treated with skin extract ........... 
Treated with placenta extract ....... 
Sta- 
Con-  tlonar2 
No. of  tinued  or sligh 
tumors  growth  retro- 
gressio~ 
~er cen$  per ce~ 
67  32.8  28.4 
75  30.7  21.3 
~ontaneou$  TlAmors 
larked 
retro- 
ression 
'@r  ce~q 
14.9 
26.7 
ornple  Total 
~bsorp  showing 
tion  inhibition 
~er ~en  per cent 
23.9  67.2 
21.3  69.3 
~xm~ 
l~  Ociginat sLze  2 ~  4 wedge 
41  l.Ofl  x  0.90 cm.  1.48  x  1.~  cm.  1.82  x  1.80 cm. 
•  •  0 
T~,eated  wkth  4~  1.19 x 0~ cm.  1.17 z 0.98  cm.  1.48 x 1.24  cm. 
and gcowth continued  O  O  O 
TExT-FIG.  1.  The average growth  rate of 43  spontaneous  tumors in  animals 
treated  with  placenta  or  embryo  skin  extracts,  which  continued  growth  after 
treatment,  compared with the average growth rate of 41  untreated  spontaneous 
tumors. 
The number of complete regressions, 32 out of 142  tumors making 
up the series (a percentage of 22.5) is striking when compared with the 
fate  of  tumors  in  untreated mice  in  which spontaneous absorption 
occurs in less than 1 per cent.  Tumors showing temporary retrogres- 
sion  followed by subsequent  growth are  not  included among those 
classed as affected by the treatment.  With untreated mice the rule 
is progressive growth until the death of the animal, but with consider- 
able variation in the growth rate of individual tumors.  Cessation of 312  INHIBITING  FACTOR  AND  SPONTANEOUS  CANCER 
growth for any great length of time is unusual# and retrogression to 
any marked degree is rarely seen.  This experience  is  in  agreement 
with Woglom's report, in which among 2000 mice with spontaneous 
tumors thirteen retrogressed and three fluctuated in growth rate, or 
remained stationary in size.  Thus 99.2  per cent of 2000  untreated 
spontaneous cancers of mice pursued "their usual progressive course." 
The Occurrence of New Primary Tumors in the Treated Groups 
It is well known that mice not uncommonly have multiple primary 
loci of malignant change in the mammary tissue, the reported figures 
on this condition yielding an average of about 18 per cent.  Haaland 
(5) collected the first systematic laboratory data and found that after 
the animal was sent into the laboratory with at least one established 
primary tumor, some 35  per  cent developed additional new tumors 
before death.  It is of interest to analyze the figures for the groups of 
mice in the above described experiments subjected to treatment with 
placenta or embryo skin extracts from the point of view of the new 
tumors developed. 
Experiment.--AU of the animals in the foregoing experiments were followed 
closely for their duration of life, and the appearance of new tumors or the finding 
of them at autopsy was recorded.  They may be considered  in two groups; one in 
which the tumors were removed,  the operative field treated with one of the extracts, 
and in which each animal received an autograft which had been immersed  in one 
of the extracts; in the second group the tumors were not removed and the mice 
received weekly  intraperitoneal injections of one of the extracts, the total number 
varying from six to fifteen.  For controls  we have two earlier series followed  in this 
laboratory, a recent series the direct control for the present experimental groups, 
and the figures  published by Haaland.  The collected  data are given in Table V. 
Here as with the other data collected from the studies of spontaneous 
cancer in mice, there is little variation between the figures collected by 
different investigators and from different strains.  The incidence of 
new tumors in the untreated animals which had previously had one or 
more  tumors,  is  37.5  per  cent,  and  the  maximum  spread  between 
groups is from 32.0 to 43.0 per cent.  Among the 210 treated mice the 
rate was 3.3 per cent, and in the 99 receiving several treatments only 
1  Slye believes that pregnancy retards the growth of spontaneous neoplasms  in 
mice (Slye,  M., 3". Cancer Research, 1920, 5, 25), but as none of the mice in our 
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one new tumor developed, or a rate of about 1 per cent.  These figures 
on the prevention of new loci of malignant change are as definite as 
those for the other points investigated.  The study is being extended 
to cover the possibility  of preventing the origin of a  first  tumor in 
mice of families normally showing a  high tumor rate.  The observa- 
TABLE  V 
Development of New  Tumors 
Controls 
Haaland* ............................... 
Nakahara* ............................. 
Early Rockefeller Institute series  .......... 
Present series  .......................... 
Total controls ............................. 
Tumors removed 
One treatment skin extract .............. 
One treatment placenta extract .......... 
Tumors not removed 
Several injections skin extract ............ 
Several injections placenta extract ........ 
Total treated ............................. 
No. of tumor  No. which  Percentsge 
animals  developed new  which developed 
tumors  new tumors 
209 
50 
138 
125 
522 
46 
65 
42 
57 
210 
73 
16 
53 
54 
196 
35.0 
32.0 
38.5 
43.2 
37.5 
6.3 
4.6 
2.4 
0.0 
3.3 
* For references see Table I. 
tion will include internal tumors  as well as  those  of  the  mammary 
gland. 
Histological Study 
The tumors composing the above described experimental material 
represent  the  usual types  of mammary gland neoplasm.  Histologi- 
cally those grafts or unoperated tumors which had been affected by 
the tissue extracts showed no striking change in their structure.  The 
only  prominent  feature  was  the  reduction  or  complete  absence  of 
mitotic  figures  in  the  tumors  after  treatment,  compared  with  the 
biopsy  sections.  There was a  suggestion of more  differentiation in 
the  treated  tumors and some  showed an increase  in the  connective 
tissue surrounding and invading the mass, but these differences were 314  INHIBITING FACTOR AND SPONTANEOUS  CANCER 
not sufficiently uniform to justify a conclusion as to their importance. 
No  increase in  cellular reaction was noted about  the grafts,  but  a 
systematic investigation of the early changes was not made.  A more 
complete study is in progress. 
DISCUSSION 
There are so many gaps in our evidence that it is untimely to discuss 
the bearing of these results on the hypothesis outlined in the foregoing 
paper (1), which has served as a basis for the investigation.  There is 
no direct evidence as yet that the factor or substance in embryo skin 
and placenta extracts is related to the hypothetical control mechanism 
for normal cells..  The lack of any reaction on the part of the host and 
the fact that the inhibitors are effective when the tumors are treated 
in ~tro before reinoculation suggest that the action is a direct one on 
the cancer cells rather than a  stimulation of the natural resistance 
mechanism of  the  body.  Stimulation  of  the  latter  is  the  general 
interpretation accorded to the results obtained with generalized X-ray, 
dry heat, and fatty acids (6) which seem to represent an entirely differ- 
ent process from the action of the inhibitors.  Our present impression 
is that the inhibitors affect directly the malignancy of the cell.  How- 
ever, any even tentative conclusion must await a more definite under- 
standing of the control mechanism of normal cells, 
The findings as concerns the various points investigated, prevention 
of postoperative  recurrence, growth of autografts,  the  stoppage  of 
further growth of well established cancer, followed in  many instances 
b~r absorption of the tumor, and the prevention of new foci of malig- 
nancy, all indicate a very definite and pronounced effect of the extract 
of  embryo  skin  and  placenta  on  the  growth  and  development  of 
malignant cells.  There were no direct controls for this series in which 
other tissue  extracts were utilized,  for such extracts had shown no 
inhibiting effect on transplanted cancer.  It was judged more impor- 
tant to test the two materials which had  proved effective with  the 
transplantable tumors on the largest possible number of spontaneous 
cancers.  We  have  records  of  unsuccessful  attempts  to  influence 
the growth of spontaneous  tumors by injection of  homologous and 
heterologous serum, red blood cells,  and a  variety  of other protein JAMES B. MURPHY AND ERNEST STURM  315 
materials which would indicate that the present  results are not due to 
some general  non-specific reaction. ~- 
SUMM~RY 
Extracts of desiccated homologous embryo skin and placenta de- 
crease markedly the rate  of postoperative local recurrence  after the 
surgical  removal  of  spontaneous  cancer  of  mice.  Autografts  after 
a  short period of contact with these extracts either failed to grow, or, 
in the majority of instances,  their  subsequent growth was definitely 
retarded.  Intraperitoneal  injection of the  extracts  was followed by 
cessation of growth of established tumors in more  than two-thirds of 
the animals  treated,  and among these many of the tumors  regressed 
and over 20 per cent were completely absorbed.  Tumor mice  treated 
with either extract rarely developed new malignant  loci, though  this 
happened frequently in untreated mice. 
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This statement  is based on an unpublished study of a large series of sponta- 
neous tumors.  No doubt other  attempts of this sort  have been made, and as 
negative results have not been reported. 